Pregnancy and infant outcomes following abatacept exposure during pregnancy.

Chambers CD, Caesar MA, Johnson DL, Xu R, Luo Y, Braddock SR, Adam MP, Robinson LK, Lyons Jones K, OTIS Collaborative Research Group, OTIS Collaborative Research Group

Open source

DOI
10.1093/rap/rkag084
Published
2026
Container
Rheumatology advances in practice
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1093/rap/rkag084,
  title = {Pregnancy and infant outcomes following abatacept exposure during pregnancy.},
  author = {Chambers CD and Caesar MA and Johnson DL and Xu R and Luo Y and Braddock SR and Adam MP and Robinson LK and Lyons Jones K and OTIS Collaborative Research Group and OTIS Collaborative Research Group},
  year = {2026},
  journal = {Rheumatology advances in practice},
  doi = {10.1093/rap/rkag084},
  url = {https://doi.org/10.1093/rap/rkag084}
}

RIS

TY  - JOUR
TI  - Pregnancy and infant outcomes following abatacept exposure during pregnancy.
AU  - Chambers CD
AU  - Caesar MA
AU  - Johnson DL
AU  - Xu R
AU  - Luo Y
AU  - Braddock SR
AU  - Adam MP
AU  - Robinson LK
AU  - Lyons Jones K
AU  - OTIS Collaborative Research Group
AU  - OTIS Collaborative Research Group
PY  - 2026
JO  - Rheumatology advances in practice
DO  - 10.1093/rap/rkag084
UR  - https://doi.org/10.1093/rap/rkag084
ER  - 

APA

CD, C., MA, C., DL, J., R, X., Y, L., SR, B., MP, A., LK, R., K, L. J., Group, O. C. R., & Group, O. C. R. (2026). Pregnancy and infant outcomes following abatacept exposure during pregnancy.. Rheumatology advances in practice. https://doi.org/10.1093/rap/rkag084

Source records